Portal de Periódicos da CAPES

Reboxetine: A Norepinephrine Selective Reuptake Pump Inhibitor

2004; Lippincott Williams & Wilkins; Volume: 10; Issue: 1 Linguagem: Inglês

10.1097/00131746-200401000-00006

1538-1145

Sheldon Preskorn,

Attention Deficit Hyperactivity Disorder

SHELDON H. PRESKORN, MD, is Professor and Chairman, Department of Psychiatry, University of Kansas School of Medicine-Wichita, and Medical Director, Psychiatric Research Institute, Wichita, Kansas. He has more than 25 years of drug development research experience at all levels (i.e., preclinical through Phase IV) and has been a principal investigator on over 150 clinical trials including every antidepressant marketed in the United States over the last 15 years. Dr. Preskorn maintains a website at where readers can access previous columns and other publications.